Perrigo Company Plc (PRGO) - Financial and Strategic SWOT Analysis Review

Date: September 27, 2016
Pages: 66
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P194EB9E87AEN
Leaflet:

Download PDF Leaflet

Perrigo Company Plc (PRGO) - Financial and Strategic SWOT Analysis Review
Perrigo Company Plc (PRGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutical ingredients (APIs), infant formulas, and consumer products. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drug, supermarket and mass merchandise chains and direct sales representatives. The company has operations in North America, Europe, Australia and other countries including Israel and China. Perrigo is headquartered in Dublin, Ireland.

Perrigo Company Plc Key Recent Developments

Aug 23, 2016: Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep Oral Solution
Aug 10, 2016: Perrigo Company Reports Second Quarter 2016 Financial Results
Jul 20, 2016: Perrigo Announces Leadership Change in Rx Pharmaceuticals Segment
May 16, 2016: Perrigo Company Reports First Quarter 2016 Financial Results
Apr 28, 2016: Perrigo Expands the Responsibilities of Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, to Lead the Branded Consumer Healthcare Segment

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Perrigo Company Plc - Key Facts
Perrigo Company Plc - Key Employees
Perrigo Company Plc - Key Employee Biographies
Perrigo Company Plc - Major Products and Services
Perrigo Company Plc - History
Perrigo Company Plc - Company Statement
Perrigo Company Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Perrigo Company Plc - Business Description
Perrigo Company Plc - Corporate Strategy
Perrigo Company Plc - SWOT Analysis
SWOT Analysis - Overview
Perrigo Company Plc - Strengths
Strength - CHC Segment
Strength - Research and Development
Strength - Prescription Pharmaceuticals (Rx Pharmaceuticals) Segment Performance
Perrigo Company Plc - Weaknesses
Weakness - Incorrect Dosage Marks
Weakness - Patent Infringement Concerns
Perrigo Company Plc - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Strategic Acquisitions
Opportunity - Growing Demand for Cosmetic and Personal Care Trends
Perrigo Company Plc - Threats
Threat - Stringent Regulations
Threat - Competitive Environment
Threat - Uncertain R&D Outcomes
Perrigo Company Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Perrigo Company Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 23, 2016: Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep Oral Solution
Aug 10, 2016: Perrigo Company Reports Second Quarter 2016 Financial Results
Jul 20, 2016: Perrigo Announces Leadership Change in Rx Pharmaceuticals Segment
May 16, 2016: Perrigo Company Reports First Quarter 2016 Financial Results
Apr 28, 2016: Perrigo Expands the Responsibilities of Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, to Lead the Branded Consumer Healthcare Segment
Apr 25, 2016: Perrigo Appoints John T. Hendrickson as Chief Executive Officer, Provides Preliminary First Quarter 2016 Selected Financial Results, and Updates Full Year 2016 Guidance
Apr 12, 2016: Perrigo Announces First-to-Market Launch of the OTC Store Brand Equivalent to Glucerna Aseptic Adult Nutritional Shake
Feb 19, 2016: Perrigo Furthers Commitment to Ireland
Feb 18, 2016: Perrigo Company Reports Record Fourth Quarter & Calendar Year Net Sales And Adjusted Net Income
Jan 11, 2016: Perrigo Company Increases 2016 Full-Year Adjusted Earnings Per Share Guidance

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Perrigo Company Plc, Key Facts
Perrigo Company Plc, Key Employees
Perrigo Company Plc, Key Employee Biographies
Perrigo Company Plc, Major Products and Services
Perrigo Company Plc, History
Perrigo Company Plc, Subsidiaries
Perrigo Company Plc, Key Competitors
Perrigo Company Plc, Ratios based on current share price
Perrigo Company Plc, Annual Ratios
Perrigo Company Plc, Interim Ratios
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Perrigo Company Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Perrigo Company Plc, Performance Chart (2011 - 2015)
Perrigo Company Plc, Ratio Charts
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
Novartis AG
Nestle S.A.
LNK International Inc.
Bayer AG
Abbott Laboratories
Skip to top


Ask Your Question

Perrigo Company Plc (PRGO) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: